相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats
Agnieszka Palucha-Poniewiera et al.
BEHAVIOURAL PHARMACOLOGY (2019)
(2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions
Panos Zanos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT2 receptors
Leandro Val Sayson et al.
PSYCHOPHARMACOLOGY (2019)
5-HT1A receptor stimulation in the medial prefrontal cortex mediates the antidepressant effects of mGlu2/3 receptor antagonist in mice
Kenichi Fukumoto et al.
NEUROPHARMACOLOGY (2018)
Liraglutide Activates mTORC1 Signaling and AMPA Receptors in Rat Hippocampal Neurons Under Toxic Conditions
Sung Woo Park et al.
FRONTIERS IN NEUROSCIENCE (2018)
Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
Eric S. Wohleb et al.
CURRENT NEUROPHARMACOLOGY (2017)
Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
Chao Dong et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities
S. E. Strasburger et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2017)
Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
Lily R. Aleksandrova et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
Depressive-like phenotype induced by prenatal dexamethasone in mice is reversed by desipramine
Mirko Conti et al.
NEUROPHARMACOLOGY (2017)
mGlu2/3 Receptor Antagonists as Novel Antidepressants
Shigeyuki Chaki
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Beyond Ketamine: New Approaches to the Development of Safer Antidepressants
Shigeyuki Chaki
CURRENT NEUROPHARMACOLOGY (2017)
Effects of escitalopram and paroxetine on mTORC1 signaling in the rat hippocampus under chronic restraint stress
Mi Kyoung Seo et al.
BMC NEUROSCIENCE (2017)
The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN
Kenichi Fukumoto et al.
NEUROPSYCHOPHARMACOLOGY (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman et al.
NATURE MEDICINE (2016)
Dexamethasone-induced acute excitotoxic cell death in the developing brain
Dmitriy A. Lanshakov et al.
NEUROBIOLOGY OF DISEASE (2016)
Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures
Ashley E. Lepack et al.
NEUROPHARMACOLOGY (2016)
Tianeptine induces mTORC1 activation in rat hippocampal neurons under toxic conditions
Mi Kyoung Seo et al.
PSYCHOPHARMACOLOGY (2016)
Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
Karolina Podkowa et al.
PSYCHOPHARMACOLOGY (2016)
Major depressive disorder
Christian Otte et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits
J. M. Witkin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
The use of ketamine as an antidepressant: a systematic review and meta-analysis
Caoimhe M. Coyle et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2015)
The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: Central mediators of pathophysiology and antidepressant activity?
Florian Freudenberg et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
BDNF Release Is Required for the Behavioral Actions of Ketamine
Ashley E. Lepack et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
Hiroyuki Koike et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Differential effects of antidepressant drugs on mTOR signalling in rat hippocampal neurons
Sung Woo Park et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures
Mi Kyoung Seo et al.
NEUROPHARMACOLOGY (2014)
Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test
Kenichi Fukumoto et al.
PSYCHOPHARMACOLOGY (2014)
Antidepressant Effects of Ketamine on Depression-like Behavior in Juvenile Mice after Neonatal Dexamethasone Exposure
Su-Xia Li et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2014)
mTOR activation is required for the antidepressant effects of mGluR2/3 blockade
Jason M. Dwyer et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Decreased expression of synapse-related genes and loss of synapses in major depressive disorder
Hyo Jung Kang et al.
NATURE MEDICINE (2012)
Signaling pathways underlying the rapid antidepressant actions of ketamine
Ronald S. Duman et al.
NEUROPHARMACOLOGY (2012)
A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists
Ronald S. Duman et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents
Ronald S. Duman et al.
TRENDS IN NEUROSCIENCES (2012)
Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression
Brice Campo et al.
JOURNAL OF NEUROGENETICS (2011)
Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists
Hiroyuki Koike et al.
NEUROPHARMACOLOGY (2011)
Metabotropic glutamate receptors as novel therapeutic targets on visceral sensory pathways
L. Ashley Blackshaw et al.
FRONTIERS IN NEUROSCIENCE (2011)
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Colleen M. Niswender et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
AMPA receptor mediates mGlu 2/3 receptor antagonist-induced dopamine release in the rat nucleus accumbens shell
Jun-ichi Karasawa et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Stress-induced dendritic remodeling in the medial prefrontal cortex: Effects of circuit, hormones and rest
Rebecca M. Shansky et al.
BRAIN RESEARCH (2009)
Treating Major Depression: Antidepressant Algorithms
Michael E. Thase
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression
Anton Y. Bespalov et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Stress, depression, and neuroplasticity: A convergence of mechanisms
Christopher Pittenger et al.
NEUROPSYCHOPHARMACOLOGY (2008)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
A role for AMPA receptors in mood disorders
A Alt et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Culturing hippocampal neurons
Stefanie Kaech et al.
NATURE PROTOCOLS (2006)
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity
S Chaki et al.
NEUROPHARMACOLOGY (2004)
Chronic antidepressant medication attenuates dexamethasone-induced neuronal death and sublethal neuronal damage in the hippocampus and striatum
LE Haynes et al.
BRAIN RESEARCH (2004)
Biolistic transfection and morphological analysis of cultured sympathetic neurons
L Klimaschewski et al.
JOURNAL OF NEUROSCIENCE METHODS (2002)
分享论文
